Table 2 Univariate analysis for coronary artery lesions

Sex, n (%)

 Male

355 (62.5)

1.0

 Female

213 (37.5)

0.79 (0.56, 1.11) 0.179

Age < 12 months, n (%)

153 (26.9)

2.08 (1.40, 3.11) < 0.001

Feeding practice, n (%)

 Formula feeding

52 (9.2)

1.0

 Partial breastfeeding

223 (39.3)

1.64 (0.78, 3.43) 0.193

 Exclusive breastfeeding

293 (51.6)

1.73 (0.84, 3.57) 0.140

Parity, n (%)

 1

301 (53.1)

1.0

 2

239 (42.2)

1.28 (0.92, 1.77) 0.144

 3

18 (3.2)

0.22 (0.03, 1.55) 0.127

 4

6 (1.1)

1.68 (0.41, 6.86) 0.470

 5

3 (0.5)

1.88 (0.26, 13.51) 0.532

Singleton, n (%)

 Yes

551 (97.2)

1.0

 No

16 (2.8)

0.70 (0.22, 2.21) 0.546

Prematurity, n (%)

 No

543 (95.9)

1.0

 Yes

23 (4.1)

0.32 (0.08, 1.30) 0.113

Delivery methods, n (%)

 Vaginal

334 (59.0)

1.0

 Cesarean

232 (41.0)

1.00 (0.72, 1.38) 0.980

IVIG resistance, n (%)

 No

542 (95.4)

1.0

 Yes

26 (4.6)

0.53 (0.22, 1.29) 0.161

Delayed IVIG treatment, n (%)

 No

528 (93.0)

1.0

 Yes

40 (7.0)

1.50 (0.89, 2.52) 0.126

iKD, n (%)

 No

447 (78.7)

1.0

 Yes

121 (21.3)

1.43 (0.99, 2.07) 0.057

WBC, × 10⁹/L

14.8 ± 5.7

1.04 (1.01, 1.07) 0.007

C-reactive protein, mg/dl

62.5 (36.4–98.0)

1.00 (1.00, 1.00) 0.334

Hemoglobin, g/L

108.8 ± 9.7

0.93 (0.91, 0.94) < 0.001

Hematocrit (× 10)

3.3 ± 0.3

0.19 (0.10, 0.34) < 0.001

Platelet, × 10⁹/L

359.0 (288.0–433.5)

1.002 (1.002, 1.003) < 0.001

Albumin, g/L

39.0 ± 3.7

0.94 (0.90, 0.98) 0.002

AST, U/L

31.9 (26.2–46.1)

1.00 (1.00, 1.00) 0.292

ALT, U/L

25.4 (15.0–67.7)

1.00 (1.00, 1.00) 0.058

Total bilirubin, umol/L

5.4 (3.8–8.5)

0.98 (0.96, 1.00) 0.084

LDH, U/L

420.4 ± 118.6

1.00 (1.00, 1.00) 0.908

Cholesterol, mmol/L

3.6 ± 0.9

0.95 (0.80, 1.12) 0.539

Creatine kinase, U/L

54.0 (38.5–77.5)

1.00 (0.99, 1.00) 0.460

Procalcitonin, ng/ml

0.5 (0.2–1.6)

0.97 (0.93, 1.02) 0.288

Serum sodium, mmol/L

134.6 ± 2.8

1.03 (0.97, 1.09) 0.330